Disruptive innovations clinical trials conference

Event contact telephone number. Dallas is home to some of the most impressive meeting spaces in Texas. The Kay Bailey Hutchison Convention Center Dallas is rated one of the top convention centers in the nation, and many Dallas hotels are well-equipped to host outstanding events of all sizes. But if you are looking for something truly unique, Dallas has plenty of that, too. Here are a few of our favorites:.

They help sites do their jobs better and more efficiently, while improving the profitability of life sciences companies. For example:. While these are sustaining to the site model, they have the potential to be disruptive in their own ways. They may also be disruptive to CROs by making it simpler and more affordable for sponsors to manage their own trials. Clinical trials could become more accessible to patients by moving clinical trial activities away from high cost, high skill, and inconvenient settings and into lower cost, lower skill, and more convenient settings.

As technology matures in these new settings, clinical trial activities will migrate to them. Pharmacies Walgreens and Novartis presented a pilot program in which an entire clinical trial was run using pharmacies alone.

Therefore, the more distributed infrastructure of pharmacies may provide patients greater accessibility to trials than investigator sites. As the locus of trials shifts closer to the patient, the technologies to capture patient data for trials need to move as well. With its roots in EDC, Medidata is expanding its cloud platform to integrate data from connected medical and mHealth devices to form a holistic view of a patient over time.

This approach to data capture is much less burdensome to patients, improving their likelihood to participate and remain engaged in trials. On the one hand, you want attendees to go to back to work with nitty gritty information they can immediately apply.

On the other hand, people need to be exposed to perspective-shifting content to encourage innovative thinking. For example, on the nitty gritty side, Donald Stanski of Novartis discussed using modeling and simulation as a disruptive quantitative tool. On the perspective-shifting side, Jon Platt of? Innovation led us through an interactive exercise to discover the creative behaviors that drive innovation. And of course, there were other great presentations along that continuum.

For example, Joe Kim of Shire discussed mobile health apps and patient recruitment. Attendees were exposed to a much needed patient perspective , which is sadly missing from many conference discussions. Jeri shared her experience with blogging about participation in an MS trial and provided her perspective on how we can make clinical trials more patient-centric. In another portion, we followed up with disruptive doers from last year.

Interviewees shared how their product developed in the last year and where they see opportunity for future disruption. Conference content was even captured in a unique content format. Jonny Goldstein of Envizualize created large visual notes of the content. He posted the full set of notes to Flickr, which you can find here. Jonny Goldstein of Envizualize took visual notes of the presentations. Check out the link above to view more of his visual conference notes.

The ability to connect with like-minded innovation lovers was at least as valuable as the content. In his comments to kick off the conference, John Orloff of Novartis noted that applying new technology to old business models is not good enough. New business models are needed. Use of technology does not make you an innovator.

In fact, technology is only getting cheaper and more accessible.